VOYAGEUR PHARMACEUTICALS LTD (VM.CA) Stock News

TSX-V:VM - CA92918C1014 - Common Stock

0.165 CAD

0 (0%)

Last: 8/29/2025, 7:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

VM.CA Latest News, Press Relases and Analysis

All

Press Releases

3 years ago - By: InvestmentPitch Media and Voyageur Pharmaceutical - Mentions: OTC

InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ Completed Production of a Test Batch of its SmoothX™ Barium Sulfate CT Contrast Media Oral Suspension for the Canadian CT Imaging Market

3 years ago - By: InvestmentPitch Media and Voyageur Pharmaceutical - Mentions: OTC

InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ Completion of the design of its Carbon Neutral Pharmaceutical Facility and Accelerated Revenue Generation Timeline for its Frances Creek Barium Sulfate Project

3 years ago - By: InvestmentPitch Media and Voyageur Pharmaceutical - Mentions: OTC

InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ MOU with Rain Cage Carbon to Develop Fullerene-Based Medical Contrast Agents from Carbon Capture of Hydrocarbon Exhaust Systems

3 years ago - By: InvestmentPitch Media and Voyageur Pharmaceutical - Mentions: OTC

InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ Notice of Work with the BC Ministry of Mines, for the Removal of 2,000 Tonnes of Barium Sulfate from its Frances Creek Project